Demystifying MetLife: Insights From 4 Analyst Reviews

Loading...
Loading...

During the last three months, 4 analysts shared their evaluations of MetLife MET, revealing diverse outlooks from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 1 3 0 0 0
Last 30D 1 0 0 0 0
1M Ago 0 0 0 0 0
2M Ago 0 2 0 0 0
3M Ago 0 1 0 0 0

Analysts have recently evaluated MetLife and provided 12-month price targets. The average target is $77.0, accompanied by a high estimate of $80.00 and a low estimate of $71.00. Observing a downward trend, the current average is 2.53% lower than the prior average price target of $79.00.

Understanding Analyst Ratings: A Comprehensive Breakdown

The standing of MetLife among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Alex Scott Goldman Sachs Announces Buy $80.00 -
Ryan Krueger Keefe, Bruyette & Woods Lowers Outperform $77.00 $79.00
Tracy Benguigui Barclays Announces Overweight $71.00 -
Nigel Dally Morgan Stanley Raises Overweight $80.00 $79.00

Key Insights:

Loading...
Loading...
  • Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to MetLife. This information provides a snapshot of how analysts perceive the current state of the company.
  • Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of MetLife compared to the broader market.
  • Price Targets: Delving into movements, analysts provide estimates for the future value of MetLife's stock. This analysis reveals shifts in analysts' expectations over time.

Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of MetLife's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.

Stay up to date on MetLife analyst ratings.

About MetLife

MetLife is one of the largest life insurers in the U.S. by assets and provides a variety of insurance and financial services products. The company is organized into five segments: U.S., Asia, Latin America, EMEA, and MetLife Holdings. The U.S. business contributes around 41% of earnings and is broken into the group benefits segment and the retirement solutions segment. The Asia segment contributes around 28% of earnings and is mainly composed of the Japan business with increasing contributions from India, China, and Bangladesh. The company also holds leading market positions in Mexico and Chile with the Latin America segment contributing around 6% of earnings. The EMEA and the MetLife segments contribute around 5% and 20% of earnings, respectively.

MetLife: A Financial Overview

Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.

Revenue Challenges: MetLife's revenue growth over 3 months faced difficulties. As of 30 September, 2023, the company experienced a decline of approximately -30.35%. This indicates a decrease in top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.

Net Margin: MetLife's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 2.69%, the company may face hurdles in effective cost management.

Return on Equity (ROE): MetLife's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.51%, the company may encounter challenges in delivering satisfactory returns for shareholders.

Return on Assets (ROA): MetLife's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.06%, the company may encounter challenges in delivering satisfactory returns from its assets.

Debt Management: With a below-average debt-to-equity ratio of 0.73, MetLife adopts a prudent financial strategy, indicating a balanced approach to debt management.

What Are Analyst Ratings?

Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...